Cargando…

Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance

OBJECTIVES: To compare the performance of the PRECISE scoring system against several MRI-derived delta-radiomics models for predicting histopathological prostate cancer (PCa) progression in patients on active surveillance (AS). METHODS: The study included AS patients with biopsy-proven PCa with a mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sushentsev, Nikita, Rundo, Leonardo, Blyuss, Oleg, Nazarenko, Tatiana, Suvorov, Aleksandr, Gnanapragasam, Vincent J, Sala, Evis, Barrett, Tristan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660717/
https://www.ncbi.nlm.nih.gov/pubmed/34255161
http://dx.doi.org/10.1007/s00330-021-08151-x
_version_ 1784613246566662144
author Sushentsev, Nikita
Rundo, Leonardo
Blyuss, Oleg
Nazarenko, Tatiana
Suvorov, Aleksandr
Gnanapragasam, Vincent J
Sala, Evis
Barrett, Tristan
author_facet Sushentsev, Nikita
Rundo, Leonardo
Blyuss, Oleg
Nazarenko, Tatiana
Suvorov, Aleksandr
Gnanapragasam, Vincent J
Sala, Evis
Barrett, Tristan
author_sort Sushentsev, Nikita
collection PubMed
description OBJECTIVES: To compare the performance of the PRECISE scoring system against several MRI-derived delta-radiomics models for predicting histopathological prostate cancer (PCa) progression in patients on active surveillance (AS). METHODS: The study included AS patients with biopsy-proven PCa with a minimum follow-up of 2 years and at least one repeat targeted biopsy. Histopathological progression was defined as grade group progression from diagnostic biopsy. The control group included patients with both radiologically and histopathologically stable disease. PRECISE scores were applied prospectively by four uro-radiologists with 5–16 years’ experience. T2WI- and ADC-derived delta-radiomics features were computed using baseline and latest available MRI scans, with the predictive modelling performed using the parenclitic networks (PN), least absolute shrinkage and selection operator (LASSO) logistic regression, and random forests (RF) algorithms. Standard measures of discrimination and areas under the ROC curve (AUCs) were calculated, with AUCs compared using DeLong’s test. RESULTS: The study included 64 patients (27 progressors and 37 non-progressors) with a median follow-up of 46 months. PRECISE scores had the highest specificity (94.7%) and positive predictive value (90.9%), whilst RF had the highest sensitivity (92.6%) and negative predictive value (92.6%) for predicting disease progression. The AUC for PRECISE (84.4%) was non-significantly higher than AUCs of 81.5%, 78.0%, and 80.9% for PN, LASSO regression, and RF, respectively (p = 0.64, 0.43, and 0.57, respectively). No significant differences were observed between AUCs of the three delta-radiomics models (p-value range 0.34–0.77). CONCLUSIONS: PRECISE and delta-radiomics models achieved comparably good performance for predicting PCa progression in AS patients. KEY POINTS: • The observed high specificity and PPV of PRECISE are complemented by the high sensitivity and NPV of delta-radiomics, suggesting a possible synergy between the two image assessment approaches. • The comparable performance of delta-radiomics to PRECISE scores applied by expert readers highlights the prospective use of the former as an objective and standardisable quantitative tool for MRI-guided AS follow-up. • The marginally superior performance of parenclitic networks compared to conventional machine learning algorithms warrants its further use in radiomics research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08151-x.
format Online
Article
Text
id pubmed-8660717
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86607172021-12-27 Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance Sushentsev, Nikita Rundo, Leonardo Blyuss, Oleg Nazarenko, Tatiana Suvorov, Aleksandr Gnanapragasam, Vincent J Sala, Evis Barrett, Tristan Eur Radiol Urogenital OBJECTIVES: To compare the performance of the PRECISE scoring system against several MRI-derived delta-radiomics models for predicting histopathological prostate cancer (PCa) progression in patients on active surveillance (AS). METHODS: The study included AS patients with biopsy-proven PCa with a minimum follow-up of 2 years and at least one repeat targeted biopsy. Histopathological progression was defined as grade group progression from diagnostic biopsy. The control group included patients with both radiologically and histopathologically stable disease. PRECISE scores were applied prospectively by four uro-radiologists with 5–16 years’ experience. T2WI- and ADC-derived delta-radiomics features were computed using baseline and latest available MRI scans, with the predictive modelling performed using the parenclitic networks (PN), least absolute shrinkage and selection operator (LASSO) logistic regression, and random forests (RF) algorithms. Standard measures of discrimination and areas under the ROC curve (AUCs) were calculated, with AUCs compared using DeLong’s test. RESULTS: The study included 64 patients (27 progressors and 37 non-progressors) with a median follow-up of 46 months. PRECISE scores had the highest specificity (94.7%) and positive predictive value (90.9%), whilst RF had the highest sensitivity (92.6%) and negative predictive value (92.6%) for predicting disease progression. The AUC for PRECISE (84.4%) was non-significantly higher than AUCs of 81.5%, 78.0%, and 80.9% for PN, LASSO regression, and RF, respectively (p = 0.64, 0.43, and 0.57, respectively). No significant differences were observed between AUCs of the three delta-radiomics models (p-value range 0.34–0.77). CONCLUSIONS: PRECISE and delta-radiomics models achieved comparably good performance for predicting PCa progression in AS patients. KEY POINTS: • The observed high specificity and PPV of PRECISE are complemented by the high sensitivity and NPV of delta-radiomics, suggesting a possible synergy between the two image assessment approaches. • The comparable performance of delta-radiomics to PRECISE scores applied by expert readers highlights the prospective use of the former as an objective and standardisable quantitative tool for MRI-guided AS follow-up. • The marginally superior performance of parenclitic networks compared to conventional machine learning algorithms warrants its further use in radiomics research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08151-x. Springer Berlin Heidelberg 2021-07-13 2022 /pmc/articles/PMC8660717/ /pubmed/34255161 http://dx.doi.org/10.1007/s00330-021-08151-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Urogenital
Sushentsev, Nikita
Rundo, Leonardo
Blyuss, Oleg
Nazarenko, Tatiana
Suvorov, Aleksandr
Gnanapragasam, Vincent J
Sala, Evis
Barrett, Tristan
Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
title Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
title_full Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
title_fullStr Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
title_full_unstemmed Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
title_short Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
title_sort comparative performance of mri-derived precise scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
topic Urogenital
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660717/
https://www.ncbi.nlm.nih.gov/pubmed/34255161
http://dx.doi.org/10.1007/s00330-021-08151-x
work_keys_str_mv AT sushentsevnikita comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT rundoleonardo comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT blyussoleg comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT nazarenkotatiana comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT suvorovaleksandr comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT gnanapragasamvincentj comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT salaevis comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance
AT barretttristan comparativeperformanceofmriderivedprecisescoresanddeltaradiomicsmodelsforthepredictionofprostatecancerprogressioninpatientsonactivesurveillance